Ceremony to launch Fresenius Kabi Bidiphar Joint Stock Co.,
03/12/2008
03/12/2008
On 1/12/2008, Binh Dinh Pharmaceutical and Medical Equipment Company (Bidiphar) and Fresenius Kabi Group (Federal Republic of Germany) held a ceremony to launch Fresenius Kabi Bidiphar Joint Stock Company.
On 1/12/2008, Binh Dinh Pharmaceutical and Medical Equipment Company (Bidiphar) and Fresenius Kabi Group (Federal Republic of Germany) held a ceremony to launch Fresenius Kabi Bidiphar Joint Stock Company.
The foreign invested joint stock Company has the charter capital of VND162 billion (USD 10 million), of which, the Fresenius Kabi Group holds 51%, Bidiphar 1 and other domestic shareholders hold 49%. Its main business lines are production and trading of pharmaceutical products, materials and machines, equipments relating to medical branch. Once operational, the company will conduct the construction of the factory producing injectable drug and transfusable products at Nhon Phu Ward, Quy Nhon City.
Fresenius Kabi AG has its head office in Federal Republic of Germany, is the leader in producing, providing health care services in Europe. Fresenius Kabi has a global network of 150 countries, achieving sales of about EUR 11.4 billion in 2007.
On this occasion, Mr Luc Depotter, Vice managing president of Fresenius Kabi in Asia - Pasific Ocean awarded 3 ambulances to the Provincial People’s Committee.
The cooperation between the two companies will create a growing export market for Bidiphar in many countries especially Europe, North America.